1 / 0

Postoperative respiratory depression associated with the perioperative use of intrathecal morphine at Auckland Hospi

Postoperative respiratory depression associated with the perioperative use of intrathecal morphine at Auckland Hospital. Nicola Broadbent Auckland City Hospital NZ. Aims. To examine the usage of intrathecal morphine at Auckland Hospital

havyn
Download Presentation

Postoperative respiratory depression associated with the perioperative use of intrathecal morphine at Auckland Hospi

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Postoperative respiratory depressionassociated with the perioperative use of intrathecal morphine at Auckland Hospital

    Nicola Broadbent Auckland City Hospital NZ
  2. Aims To examine the usage of intrathecalmorphine at Auckland Hospital Identify associated post-operative respiratory depression and/or sedation
  3. Design Northern X Regional Ethics Committee and ADHB Research Office approval Retrospective 12 month period Sept 2008 - Sept 2009 Patient group Patients aged 16 years and over Single dose of intrathecal morphine Surgical procedures excluding obstetric and cardiac bypass procedures Controlled drug register Notes review to confirm administration Database compilation
  4. Event data 24 hr period post intrathecal morphine dose Observations Respiratory rate <8/min SpO2<90% GCS<9 Worst AVPU score Interventions Medical review sedation +/- respiratory rate Naloxone administration Code Red/Blue HDU/ICU admission
  5. Patient characteristics
  6. Surgical speciality 429 patients underwent 438 procedures 9 patients had 2 procedures
  7. Anaesthesia
  8. Intrathecal morphine dose Dose range 50-500mcg Mean dose 158.5mcg Median dose 150 mcg 37 (8.4%) received a dose > 200mcg Intrathecal morphine dose (mcg)
  9. Complications * 1 patient had preoperative hypoxia
  10. Patients receiving naloxone
  11. Opioid consumption
  12. Sedative co-analgesics
  13. Events by speciality High incidence of events requiring intervention in general surgical group Hepatobilary patients responsible for all medical reviews and naloxone in this group
  14. Hepatobiliary subgroup Predominant group contributing to respiratory and sedation events 36/37 received dose of 200mcg or greater Range 175-300mcg Mean 252 mcg Median 250mcg
  15. How does this audit fit in the literature?
  16. In summary In this retrospective QA project 12.1% had a respiratory or sedative complication 3.4% triggered a medical review 1.37% needed iv naloxone for respiratory depression +/- sedation Features Respiratory depression delayed 3.3-14.5 hr post dose General surgical/hepatobiliary patients over-represented Larger intrathecal morphine doses Early iv morphine prior to PACU discharge Gabapentin premedication Conclusions Orthopaedic patients can be nursed in ward setting with appropriate observations Consider HDU placement for general surgical/hepatobiliary patients Caution with early opiates and consider short acting opiates (egfentanyl) for bridging Caution with gabapentin premedication
  17. Optimum dosing Optimization of the Dose of Intrathecal Morphine in Total Hip Surgery: A Dose-Finding Study Robert Slappendel et al. Anesth Anal 1999 88:822-6 143 pt receiving either 25,50,100,200mcg followed for 24hr Optimal dose as low as 0.1mg. 0.2mg did not improve analgesia but increased side effects Optimizing the dose of Intrathecal Morphine in Older Patients Undergoing Hip Arthroplasty Laffey et al Anesth Anal 2003. 97: 1709-15 60 pt receiving either 0, 50, 100, 200mcg followed for 24hr 100mcg morphine provides best balance between analgesic efficacy Minimal effective dose of Intrathecal morphine for Pain Relief Following Transabdominal Hysterectomy Watanabe et al Anesth Anal 1989 188 pt receiving 30,40,60,80,100mcg followed for 48hr Effective analgesia at 40mcg.
  18. Hepatobiliary patients in the literature 2 recent studies The use of intrathecal morphine for postoperative pain relief after liver resection: A comparison with epidural analgesia De Pietri et al Anesth Anal 2006 A change in practice from epidural to intrathecal morphine analgesia for hepato-pancreato-biliary surgery Sakowska et al World J Surg 2009
  19. Defining respiratory depression What do we mean? Inadequate ventilation? Bradypnoea? Failure to oxygenate and clear waste gases? What can we measure on the ward? Definitions of "respiratory depression" with intrathecal morphine postoperative analgesia: a review of the literature Goldstein et al. Can J Anesth 2003 96 studies 46% did not define “respiratory depression” when used 25% defined by respiratory rate alone SpO2, ABG, naloxone treatment, carbon dioxide stimulation, level of sedation
  20. Data collected Patient demographics Intrathecal morphine dose Surgical and anaesthetic details Other opioids Early morphine consumption prior to PACU discharge Presence/absence of PCA Opioid usage over 24hr Sedative co-analgesics Gabapentin premedication Ketamine Clonidine Dexmedetomidine Pain scores
  21. Bradypnoea (APS guidelines) Local guidelines recommend treatment with naloxone if RR <8/min and unrousable 5.2% had a RR of <8/min documented 1.7% on surgical ward 1 given naloxone
More Related